Protein Intake Dosage on the Prognosis of Neurocritical Patients

This study investigates the effect of different early protein supplementation levels (1.0-2.0g/kg/d, divided into three groups) on the prognosis of neurocritical patients, focusing on the 28-day Glasgow Coma Scale (GCS) score improvement rate. Participants will be randomly assigned to receive varying protein doses, and their short-term (28-day mortality, ICU stay, complications) and long-term (90-day mortality, readmission rate) clinical outcomes will also be compared.

NCT Number	NCT07295301
Lead Sponsor	Wenshan City People's Hospital
Conditions	Neurocritical Conditions, Traumatic Brain Injury, Ischemic Stroke
Enrollment	216 participants
Start Date	2025-12
Primary Completion	2028-06 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2025-12-19